Latest Breaking News On - Paediatric rheumatology - Page 5 : comparemela.com
HBKU workshop equips physicians to analyse genetic variation
gulf-times.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gulf-times.com Daily Mail and Mail on Sunday newspapers.
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis | Critical Care Medicine | JAMA
jamanetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jamanetwork.com Daily Mail and Mail on Sunday newspapers.
Updated:
What we have learnt about treatment so far
Share Article
AAA
A health worker takes a swab sample at a coronavirus testing centre, in Chennai. File
| Photo Credit:
B. Jothi Ramalingam
What we have learnt about treatment so far
The SARS-CoV-2 pandemic was declared by the World Health Organization (WHO) on March 11, 2020. The SARS-CoV-2 infection causes COVID-19. Doctors initially did not know how best to treat patients with COVID-19. Thus, in the first few months, clinical care was dominated by opinion, anecdotes and dogma. An example is the hype surrounding hydroxychloroquine as a potential cure for COVID-19. It took a huge global effort to prove that hydroxychloroquine does not benefit COVID-19 patients. One year on, there is still rampant misinformation on cures for COVID-19, with steam inhalation, multivitamins, mineral supplements, and drugs such as ivermectin, and chloroquine, all of which have not been demonstrated to treat COVID-19, still being prescribed.
Arthritis Drug Tocilizumab Reduces Severe Covid Mortality: Study By Patrick GALEY
02/11/21 AT 10:00 AM
The arthritis drug tocilizumab reduces the risk of critically ill patients dying of Covid-19, according to results of a study on Thursday which experts welcomed as an exciting development.
The Britain-based RECOVERY research programme investigating Covid-19 treatments said their findings could have a significant effect on hospital survival rates during the pandemic.
The study included more than 2,000 patients who received the drug intravenously compared with nearly 3,000 who were given normal care alone, such as oxygen support and ventilation.
More than 80 percent of all the patients were also receiving steroid treatments such as dexamethasone, which had been shown in earlier trials to lower the risk of death.
vimarsana © 2020. All Rights Reserved.